论文部分内容阅读
Left main (LM) stenting is considered by many to be one of the last frontiers of interventional cardiology. Beginning with the VA cooperative study published in 1976 demonstrating a mortality benefit for patients undergoing coronary artery bypass grafting (CABG), the standard of care for treatment of left main coronary artery disease has been surgical. The most recent 2005 update of the ACC/AHA/SCAI Practice Guidelines on PCI again notes that “CABG using IMA grafting is the ’gold standard’ for treatment of unprotected left main disease and has proven benefit on long-term outcomes”
Left main (LM) stenting is considered by many to be one of the last frontiers of interventional cardiology. Beginning with the VA cooperative study published in 1976 demonstrations a mortality benefit for patients undergoing coronary artery bypass grafting (CABG), the standard of care for treatment of left main coronary artery disease has been surgical. The most recent 2005 update of the ACC / AHA / SCAI Practice Guidelines on PCI again notes that “CABG using IMA grafting is the ’gold standard’ for treatment of unprotected left main disease and has proven benefit on long-term outcomes ”